Skip to main content

International Conference on Frailty and Sarcopenia Research 2025

March 14, 2025 | Toulouse, FR

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

“Novel Gerotherapeutic Peptides Alleviate Sarcopenia and Frailty In Naturally Aged Mice By Dual Mechanisms Acting Through a Single Aging-Selective Target”

International Conference on Frailty and Sarcopenia Research 2025 – oral communication on the plenary session of the International Conference of Frailty and Sarcopenia Research 2025

Plenary Session OC29
11:50 a.m. in Toulouse, France, (5:50 A.M. EST)